Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function

American Journal of Physiology - Endocrinology and Metabolism

Volumn 307, Issue 6, 2014, Pages E494-E502

  Hinshaw, Ling ^a   Schiavon, Michele ^b   Mallad, Ashwini ^a   Dalla Man, Chiara ^b   Basu, Rita ^a   Bharucha, Adil E ^c   Cobelli, Claudio ^b   Carter, Rickey E ^c   Basu, Ananda ^a   Kudva, Yogish C ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Gastric emptying; Insulin action; Pramlintide

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PRAMLINTIDE; AMYLIN; ANTIDIABETIC AGENT; DIAGNOSTIC AGENT;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIET RESTRICTION; FAT FREE MASS; FEASIBILITY STUDY; FEMALE; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; POSTPRANDIAL STATE; SINGLE DRUG DOSE; STOMACH EMPTYING; TEST MEAL; TREADMILL EXERCISE; VOLUME OF DISTRIBUTION; ADOLESCENT; ALGORITHM; BLOOD; FOOD; HYPERGLYCEMIA; INSULIN ACTION; INSULIN RESISTANCE; KINETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; YOUNG ADULT;

GASTRIC EMPTYING; INSULIN ACTION; PRAMLINTIDE;

ADOLESCENT; ADULT; ALGORITHMS; BLOOD GLUCOSE; C-PEPTIDE; FEMALE; FOOD; GASTRIC EMPTYING; GLUCAGON; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ISLET AMYLOID POLYPEPTIDE; KINETICS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84907779009     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00199.2014     Document Type: Article

References (43)

1. Basu A, Dalla Man C, Basu R, Toffolo G, Cobelli C, Rizza RA. Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Diabetes Care 32: 866–872, 2009.
2. Basu R, Dalla Man C, Campioni M, Basu A, Klee G, Toffolo G, Cobelli C, Rizza RA. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 55: 2001–2014, 2006.
3. Basu R, DiCamillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R., Cobelli C. Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab 284: E55–E69, 2003.
4. Bharucha AE, Camilleri M, Forstrom LA, Zinsmeister AR. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf) 70: 415–420, 2009.
5. Burmeister MA, Ferre T, Ayala JE, King EM, Holt RM. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice. Am J Physiol Endocrinol Metab 302: E334–E343, 2012.
6. Campioni M, Toffolo G, Basu R, Rizza R., Cobelli C. Minimal model assessment of hepatic insulin extraction during an oral test from standard insulin kinetic parameters. Am J Physiol Endocrinol Metab 297: E941–E948, 2009.
7. Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Lush CW, Chen K, Lacerte C, Burns C, McKay R, Weyer C, Horowitz M. Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects. Obesity (Silver Spring) 15: 1179–1186, 2007.
8. Cobelli C, Dalla Man C, Toffolo G, Basu R, Vella A, Rizza R. The oral minimal model method. Diabetes 63: 1203–1213, 2014.
9. Cobelli C., Ferrannini E. A model of glucose kinetics and their control by insulin, compartmental and non-compartmental approaches. Math Biosci 72: 291–315, 1984.
10. Dalla Man C, Campioni M, Polonsky KS, Basu R, Rizza R., Toffolo G, Cobelli C. Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes 54: 3265–3273, 2005.
11. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am J Physiol Endocrinol Metab 287: E637–E643, 2004.
12. Dalla Man C, Caumo A, Cobelli C. The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans Biomed Eng 49: 419–429, 2002.
13. Dalla Man C, Piccinini F, Basu R, Basu A, Rizza R., Cobelli C. Modeling hepatic insulin sensitivity during a meal: validation against the euglycemic hyperinsulinemic clamp. Am J Physiol Endocrinol Metab 304: E819–E825, 2013.
14. Elleri D, Allen JM, Harris J, Kumareswaran K, Nodale M, Leelarathna L, Acerini CL, Haidar A, Wilinska ME, Jackson N, Umpleby AM, Evans ML, Dunger DB, Hovorka R. Absorption patterns of meals containing complex carbohydrates in type 1 diabetes. Diabetologia 56: 1108–1117, 2013.
15. Ferrannini E, Simonson DC, Katz LD, Reichard G Jr, Bevilacqua S, Barrett EJ, Olsson M, DeFronzo RA. The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 37: 79–85, 1988.
16. Heptulla RA, Rodriguez LM, Bomgaars L, Haymond MW. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes 54: 1100–1107, 2005.
17. Heptulla RA, Rodriguez LM, Mason KJ, Haymond MW. Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetes. Pediatr Diabetes 9: 561–566, 2008.
18. Hinshaw L, Dalla Man C, Nandy DK, Saad A, Bharucha AE, Levine JA, Rizza R., Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes 62: 2223–2229, 2013.
19. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharmaceut Stat 4: 287–291, 2005.
20. Kong MF, King P, Macdonald IA, Stubbs TA, Perkins AC, Blackshaw PE, Moyses C, Tattersall RB. Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia 40: 82–88, 1997.
21. Kong MF, Stubbs TA, King P, Macdonald IA, Lambourne JE, Blackshaw PE, Perkins AC, Tattersall RB. The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM. Diabetologia 41: 577–583, 1998.
22. Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman O., Chandran M, Mudaliar SR, Henry RR. Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. Diabetes Care 26: 1–8, 2003.
23. Livesey G, Wilson PD, Dainty JR, Brown JC, Faulks RM, Roe MA, Newman TA, Eagles J, Mellon FA, Greenwood RH. Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes. Am J Physiol Endocrinol Metab 275: E717–E728, 1998.
24. Mari A, Wahren J, DeFronzo RA, Ferrannini E. Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. Metabolism 43: 1419–1425, 1994.
25. Micheletto F, Dalla Man C, Kolterman O, Chiquette E, Herrmann K, Schirra J, Kovatchev B, Cobelli C. In Silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes. Diabetes Technol Ther 15: 802–809, 2013.
26. Moyses C, Young A, Kolterman O. Modulation of gastric emptying as a therapeutic approach to glycaemic control. Diabet Med 13: S34–S38, 1996.
27. Nauck MA, Kemmeries G, Holst JJ, Meier JJ. Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans. Diabetes 60: 1561–1565, 2011.
28. Pereira S, Park E, Mori Y, Haber CA, Han P, Uchida T, Stavar L, Oprescu AI, Koulajian K, Ivovic A, Yu Z, Li D, Bowman TA, Dewald J, El-Benna J, Brindley DN, Gutierrez-Juarez R, Lam TK, Najjar SM, McKay RA, Bhanot S, Fantus IG, Giacca A. FFA-induced hepatic insulin resistance in vivo is mediated by PKC, NADPH oxidase, and oxidative stress. Am J Physiol Endocrinol Metab 307: E34–E46, 2014.
29. Radziuk J, Norwich KH, Vranic M. Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol Endocrinol Metab Gastrointest Physiol 234: E84–E93, 1978.
30. Saad A, Dalla Man C, Nandy DK, Levine JA, Bharucha AE, Rizza R., Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes 61: 2691–2700, 2012.
31. Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol 278: G946–G951, 2000.
32. Samsom M, Vermeijden JR, Smout AJ, Van Doorn E, Roelofs J, Van Dam PS, Martens EP, Eelkman-Rooda SJ, Van Berge-Henegouwen GP. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care 26: 3116–3122, 2003.
33. Talley NJ, Phillips SF, Melton J, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 111: 671–674, 1989.
34. Toffolo G, Basu R, Dalla Man C, Rizza R, Cobelli C. Assessment of postprandial glucose metabolism: conventional dualvs. triple-tracer method. Am J Physiol Endocrinol Metab 291: E800–E806, 2006.
35. Toffolo G, Breda E, Cavaghan MK, Ehrmann DA, Polonsky KS, Cobelli C. Quantitative indexes of cell function during graded up&down glucose infusion from C-peptide minimal models. Am J Physiol Endocrinol Metab 280: E2–E10, 2001.
36. Van Belle G. Statistical Rules of Thumb (2nd Ed). New York: John Wiley & Sons, 2008.
37. Vella A, Lee JS, Camilleri M, Szarka LA, Burton DD, Zinsmeister AR, Rizza R., Klein PD. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil 14: 123–131, 2002.
38. Vestergaard ET, Djurhuus CB, Gjedsted J, Nielsen S, Møller N, Holst JJ, Jørgensen JO, Schmitz O. Acute effects of ghrelin administration on glucose and lipid metabolism. J Clin Endocrinol Metab 93: 438–444, 2008.
39. Vestergaard ET, Gormsen LC, Jessen N, Lund S, Hansen TK, Moller N, Jorgensen JO. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 57: 3205–3210, 2008.
40. Weinzimer SA, Sherr JL, Cengiz E, Kim G, Ruiz JL, Carria L, Voskanyan G, Roy A, Tamborlane WV. Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care 35: 1994–1999, 2012.
41. Woerle HJ, Albrecht M, Linke R, Zschau S, Neumann C, Nicolaus M, Gerich J, Goke B, Schirra J. Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans. Am J Physiol Endocrinol Metab 294: E103–E109, 2008.
42. Woerle HJ, Albrecht M, Linke R, Zschau S, Neumann C, Nicolaus M, Gerich JE, Göke B, Schirra J. Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide. Diabetes Care 31: 2325–2331, 2008.
43. Young AA, Gedulin B, Vine W, Percy A, Rink TJ. Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 38: 642–648, 1995.